Ankylosing Spondylitis
&nbsp;
Ankylosing Spondylitis (AS), also called Bechterew's disease, is a common inflammatory rheumatic disease that affects the axial skeleton, causing characteristic inflammatory back pain, which can lead to structural and functional impairments and a decrease in quality of life.
Ankylosing spondylitis usually starts with dull pain in the lower back and back stiffness. Some people with ankylosing spondylitis have "flares" of increased pain and stiffness that may last for several weeks before decreasing again.
&nbsp;
Ankylosing Spondylitis Epidemiology Segmentation in the 7MM
&nbsp;
<ul>
<li>&nbsp;Total Prevalent cases of Ankylosing Spondylitis</li>
<li>&nbsp;Diagnosed Prevalent cases of Ankylosing Spondylitis&nbsp;&nbsp;</li>
<li>Gender-specific Diagnosed Prevalent cases of Ankylosing Spondylitis&nbsp;&nbsp;</li>
<li>Age-specific Diagnosed Prevalent Cases of Ankylosing Spondylitis</li>
<li class="ql-align-justify">Gene-specific Diagnosed Prevalent cases of Ankylosing Spondylitis&nbsp;&nbsp;&nbsp;</li>
</ul>
&nbsp;
<a style="color: #1155cc; background-color: transparent;" href="https://www.delveinsight.com/report-store/ankylosing-spondylitis-bekhterevs-disease-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Ankylosing Spondylitis Epidemiological Insights</a> Observed in the 7MM
(2021)
&nbsp;
<ul>
<li class="ql-align-justify">The total incident cases of Ankylosing Spondylitis observed in the 7MM were observed to be 2.2 Million in the year 2021</li>
</ul>
&nbsp;
<a style="color: #1155cc; background-color: transparent;" href="https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market" target="_blank" rel="noopener noreferrer">Ankylosing Spondylitis Market Insight</a>
&nbsp;
The market size of Ankylosing Spondylitis in the 7MM was found to be approximately USD 4200 Million in 2021. &nbsp;
&nbsp;
Ankylosing Spondylitis Market Strengths
&nbsp;
Certain initiatives have been taken by private and government organizations to raise awareness about the disease, like SpA Awareness Month in May.&nbsp;
&nbsp;
Ankylosing Spondylitis Market Opportunities
&nbsp;
Several pharmaceutical key players have taken the initiative to meet the unmet needs of the AS market&rsquo;s present situation.
&nbsp;
<a style="color: #1155cc; background-color: transparent;" href="https://www.delveinsight.com/report-store/ankylosing-spondylitis-bekhterevs-disease-pipeline-insight" target="_blank" rel="noopener noreferrer">Ankylosing Spondylitis Emerging Drugs</a>
&nbsp;
The emerging drugs in the Ankylosing Spondylitis market are
●&nbsp;&nbsp;&nbsp;&nbsp;Bimekizumab
●&nbsp;&nbsp;&nbsp;&nbsp;CC-99677
●&nbsp;&nbsp;&nbsp;&nbsp;ABY- 035, and others
&nbsp;
Ankylosing Spondylitis Key Players&nbsp;
&nbsp;
The key players working in the Ankylosing Spondylitis market are
&nbsp;
<ul>
<li class="ql-align-justify">UCB Biopharma</li>
<li class="ql-align-justify">Celgene</li>
<li>Inmagene Biopharmaceuticals and others</li>
</ul>

Ankylosing Spondylitis Market

Ankylosing Spondylitis Market Infographic covers detailed assessment into the Treatment, epidemiology, companies, and emerging drugs